Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-27 @ 11:07 AM
Study NCT ID:
NCT01093534
Status:
COMPLETED
Last Update Posted:
2024-12-03
First Post:
2010-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01-19
Start Date Type:
ACTUAL
Primary Completion Date:
2011-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-24
First Submit QC Date:
None
Study First Post Date:
2010-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-02-26
Results First Submit QC Date:
None
Results First Post Date:
2014-04-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-09-06
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-11-12
Last Update Post Date:
2024-12-03
Last Update Post Date Type:
ACTUAL